UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143 | -48.0% | 10,189 | -67.2% | 0.01% | -64.7% |
| Q4 2022 | $275 | -99.9% | 31,046 | -36.9% | 0.03% | -37.0% |
| Q3 2022 | $410,000 | +3.8% | 49,222 | +2.0% | 0.05% | -8.5% |
| Q2 2022 | $395,000 | -20.7% | 48,271 | -15.6% | 0.06% | -11.9% |
| Q1 2022 | $498,000 | +34.2% | 57,224 | +46.5% | 0.07% | +42.6% |
| Q4 2021 | $371,000 | +7.5% | 39,064 | +90.5% | 0.05% | +34.3% |
| Q3 2021 | $345,000 | -19.0% | 20,505 | -26.5% | 0.04% | -27.1% |
| Q2 2021 | $426,000 | -7.2% | 27,883 | +18.4% | 0.05% | -36.8% |
| Q1 2021 | $459,000 | +20.8% | 23,544 | +130.8% | 0.08% | +230.4% |
| Q4 2017 | $380,000 | +29.7% | 10,200 | +9.7% | 0.02% | +15.0% |
| Q3 2017 | $293,000 | – | 9,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |